Table 1 Demographics of the US birth cohort and of women undergoing ART 2004–2013
| Â | Non-Hispanic White | Non-Hispanic Black | Asian/Pacific Islander | Hispanic | Other | Missing | |
|---|---|---|---|---|---|---|---|
American Indian/Alaska Native | Multi-Race | ||||||
Autologous ART cycles | 515,263 | 50,298 | 87,845 | 58,494 | 1462 | 2966 | 416,516 |
3ART cycles | 101,454 | 8764 | 13,635 | 9715 | 216 | 988 | 82,258 |
Race Distribution | |||||||
 US Birth Cohort (40,942,262 birth) | 54.3% | 14.6% | 6.1% | 23.8% | 1.1% | - | - |
 Autologous ART | 72.2% | 7.1% | 12.3% | 8.2% | 0.2% | - | - |
 3ART | 75.8% | 6.6% | 10.2% | 7.3% | 0.2% | - | - |
  Oocyte Donation | 74.5% | 6.7% | 11.8% | 6.9% | 0.2% | - | - |
  Sperm Donation | 76.7% | 8.6% | 6.6% | 8.0% | 0.2% | - | - |
  Embryo Donation | 88.1% | 3.7% | 3.4% | 4.7% | 0.1% | - | - |
  Gestational Carrier | 76.4% | 3.9% | 10.5% | 9.1% | 0.1% | - | - |
  Multiple 3ART | 78.6% | 4.9% | 7.9% | 8.5% | 0.1% | - | - |
Mean Age ± SD | |||||||
 US First Birth, 2013 | 26.8 | 23.9 | 29.4 | 24.0 | 22.9 | - | - |
 Autologous ART | 35.4 ± 4.7 | 36.3 ± 4.9 | 36.0 ± 4.5 | 35.8 ± 4.9 | 35.6 ± 4.6 | 36.1 ± 4.8 | 36.1 ± 4.8 |
 3ART | 40.1 ± 5.5 | 41.6 ± 5.4 | 41.3 ± 5.6 | 40.1 ± 5.9 | 40.1 ± 5.5 | 41.3 ± 5.1 | 40.6 ± 5.3 |
Age Distribution | |||||||
 Autologous ART | |||||||
  <35 | 46.4% | 38.0% | 40.4% | 42.0% | 47.3% | 40.7% | 40.6% |
  35–37 | 22.5% | 22.2% | 24.2% | 22.7% | 20.6% | 21.8% | 22.7% |
  38–40 | 18.5% | 22.0% | 20.6% | 20.4% | 18.3% | 21.1% | 20.6% |
  41–42 | 4.6% | 5.7% | 5.2% | 5.2% | 4.9% | 5.6% | 5.5% |
  >42 | 8.0% | 12.2% | 9.7% | 9.7% | 9.0% | 10.8% | 10.6% |
 3ART | |||||||
   < 35 | 16.2% | 9.8% | 12.5% | 17.7% | 18.1% | 9.7% | 13.6% |
  35–37 | 12.9% | 9.7% | 11.5% | 12.7% | 13.4% | 11.1% | 12.1% |
  38–40 | 18.7% | 17.7% | 17.1% | 17.5% | 17.1% | 17.8% | 18.6% |
  41–42 | 8.2% | 8.2% | 6.6% | 7.4% | 9.3% | 6.8% | 8.2% |
   > 42 | 44.0% | 54.7% | 52.3% | 44.8% | 42.1% | 54.6% | 47.6% |
Infertility Diagnosis | |||||||
 Male Infertility | 36.4% | 31.9% | 33.6% | 36.2% | 31.4% | 32.1% | 32.2% |
 Endometriosis | 12.0% | 7.2% | 10.0% | 10.1% | 9.4% | 8.5% | 9.9% |
 Polycystic Ovaries | 15.3% | 11.0% | 13.8% | 13.2% | 19.2% | 11.1% | 12.5% |
 Diminished Ovarian Reserve | 27.6% | 27.3% | 31.0% | 24.8% | 23.1% | 36.6% | 27.4% |
 Tubal | 14.0% | 35.5% | 14.1% | 24.2% | 22.2% | 16.0% | 16.0% |
 Uterine | 4.7% | 12.9% | 5.2% | 5.3% | 4.9% | 6.4% | 6.4% |
 Unexplained | 11.2% | 6.4% | 12.7% | 8.0% | 8.5% | 10.4% | 13.8% |
 Other | 15.0% | 13.2% | 14.1% | 15.6% | 16.8% | 16.8% | 15.1% |